|
|
Surgical Management of Cervical Spondylosis Myelopathy
|
Abstract:
This retrospective study evaluates the surgical outcomes of 53 patients treated for cervical spondylosis myelopathy (CSM) at the Department of Neurosurgery, Teaching Hospital of Conakry at University of Gamal Abdel Nasser in Guinea between January, 1st, 2019 and December 31st, 2025. The authors analyze clinical improvements using JOA scores, Nurick grades, and NDI scores, alongside surgical approaches and complications. The study concludes that surgical decompression significantly improves neurological function and prevents further decline in this patient population.
| [1] | Marie-Hardy, L. and Pascal-Moussellard, H. (2021) Degenerative Cervical Myelopathy. Revue Neurologique, 177, 490-497. https://doi.org/10.1016/j.neurol.2020.11.015 |
| [2] | Hejrati, N., Pedro, K., Alvi, M.A., Quddusi, A. and Fehlings, M.G. (2023) Degenerative Cervical Myelopathy: Where Have We Been? Where Are We Now? Where Are We Going? Acta Neurochirurgica, 165, 1105-1119. https://doi.org/10.1007/s00701-023-05558-x |
| [3] | Hejrati, N., Moghaddamjou, A., Marathe, N. and Fehlings, M.G. (2021) Degenerative Cervical Myelopathy: Towards a Personalized Approach. Canadian Journal of Neurological Sciences/Journal Canadien des Sciences Neurologiques, 49, 729-740. https://doi.org/10.1017/cjn.2021.214 |
| [4] | Gallagher, D.O., Taghlabi, K.M., Bondar, K. and Saifi, C. (2023) Degenerative Cervical Myelopathy: A Concept Review and Clinical Approach. Clinical Spine Surgery, 37, 1-8. https://doi.org/10.1097/bsd.0000000000001463 |
| [5] | Rajan, P.V., Pelle, D.W. and Savage, J.W. (2022) New Imaging Modalities for Degenerative Cervical Myelopathy. Clinical Spine Surgery, 35, 422-430. https://doi.org/10.1097/bsd.0000000000001408 |
| [6] | Janich, K.W. and Wang, M.C. (2023) Editorial. Cervical Laminoplasty for Degenerative Cervical Myelopathy: Still Much More to Learn. Journal of Neurosurgery: Spine, 38, 1-3. https://doi.org/10.3171/2022.5.spine22374 |
| [7] | Satin, A.M., Rush, A.J. and Derman, P.B. (2022) Review of Prospective Trials for Degenerative Cervical Myelopathy. Clinical Spine Surgery, 35, 410-417. https://doi.org/10.1097/bsd.0000000000001407 |
| [8] | Davenport, R., Jandzinski, M., Ahmed, M., Stino, A. and Aleem, I. (2022) Electrodiagnostic Studies in Degenerative Cervical Myelopathy. Clinical Spine Surgery, 35, 403-409. https://doi.org/10.1097/bsd.0000000000001413 |
| [9] | Sarraj, M., Hache, P., Foroutan, F., Oitment, C., Marion, T.E., Guha, D., et al. (2024) Natural History of Degenerative Cervical Myelopathy: A Meta-Analysis and Neurologic Deterioration Survival Curve Synthesis. The Spine Journal, 24, 46-56. https://doi.org/10.1016/j.spinee.2023.07.020 |
| [10] | Houten, J.K., Shahsavarani, S. and Verma, R.B. (2022) The Natural History of Degenerative Cervical Myelopathy. Clinical Spine Surgery, 35, 396-402. https://doi.org/10.1097/bsd.0000000000001405 |
| [11] | Nouri, A., Tetreault, L., Singh, A., Karadimas, S.K. and Fehlings, M.G. (2015) Degenerative Cervical Myelopathy: Epidemiology, Genetics, and Pathogenesis. Spine, 40, E675-E693. https://doi.org/10.1097/brs.0000000000000913 |
| [12] | Fehlings, M.G., Tetreault, L.A., Riew, K.D., Middleton, J.W., Aarabi, B., Arnold, P.M., et al. (2017) A Clinical Practice Guideline for the Management of Patients with Degenerative Cervical Myelopathy: Recommendations for Patients with Mild, Moderate, and Severe Disease and Nonmyelopathic Patients with Evidence of Cord Compression. Global Spine Journal, 7, 70S-83S. https://doi.org/10.1177/2192568217701914 |
| [13] | Tetreault, L., Kopjar, B., Nouri, A., Arnold, P., Barbagallo, G., Bartels, R., et al. (2016) The Modified Japanese Orthopaedic Association Scale: Establishing Criteria for Mild, Moderate and Severe Impairment in Patients with Degenerative Cervical Myelopathy. European Spine Journal, 26, 78-84. https://doi.org/10.1007/s00586-016-4660-8 |
| [14] | Jiang, Z., Davies, B., Zipser, C., Margetis, K., Martin, A., Matsoukas, S., et al. (2023) The Value of Clinical Signs in the Diagnosis of Degenerative Cervical Myelopathy—A Systematic Review and Meta-Analysis. Global Spine Journal, 14, 1369-1394. https://doi.org/10.1177/21925682231209869 |
| [15] | Çolak, A., Kelten, B., Sağmanligil, A., Akdemir, O., Karaoğlan, A., Şahan, E., et al. (2008) Tauroursodeoxycholic Acid and Secondary Damage after Spinal Cord Injury in Rats. Journal of Clinical Neuroscience, 15, 665-671. https://doi.org/10.1016/j.jocn.2007.06.002 |
| [16] | Iannotti, C., Pingzhang, Y., Shields, C., Han, Y., Burke, D. and Xu, X. (2004) A Neuroprotective Role of Glial Cell Line-Derived Neurotrophic Factor Following Moderate Spinal Cord Contusion Injury. Experimental Neurology, 189, 317-332. https://doi.org/10.1016/j.expneurol.2004.05.033 |
| [17] | Michael-Titus, A.T. (2007) ω-3 Fatty Acids and Neurological Injury. Prostaglandins, Leukotrienes and Essential Fatty Acids, 77, 295-300. https://doi.org/10.1016/j.plefa.2007.10.021 |
| [18] | Tederko, P., Krasuski, M., Kiwerski, J., Nyka, I. and Białoszewski, D. (2009) Strategies for Neuroprotection Following Spinal Cord Injury. Ortopedia Traumatologia Rehabilitacja, 11, 103-110. |
| [19] | Sousa, C.S., Lima, R., Cibrão, J.R., Gomes, E.D., Fernandes, L.S., Pinho, T.S., Silva, D., Campos, J. and Salgado, A.J. (2023) Silva Pre-Clinical Assessment of Roflumilast Therapy in a Thoracic-Model of Spinal Cord Injury. Pharmaceutics, 15, Article 1556. https://doi.org/10.3390/pharmaceutics15051556 |
